Heartbeam Inc.

HeartBeam Inc. is a medical device company that has developed the AIMIGo™, a portable cardiac monitoring system designed to capture clinical-grade ECG data outside traditional healthcare settings. The credit card-sized device enables patients to record ECG readings at home or on-the-go, with recordings transmitted to a cloud-based platform for interpretation by on-call cardiologists.

The company's primary innovation centers on synthesizing a 12-lead ECG from a compact, cable-free device that patients can operate independently. The HeartBeam System includes the AIMIGo device, patient-facing mobile application with step-by-step guidance, cloud infrastructure for data transmission, and access to cardiologist review services. The technology aims to bridge the gap between traditional 12-lead ECG equipment that requires healthcare professionals and consumer wearables that may lack clinical-grade accuracy.

HeartBeam has received FDA clearance for its device and garnered multiple industry awards, including the 2024 MedTech Breakthrough Award. The 12-lead synthesis software is not yet cleared by the FDA and is not available for sale in the United States. The company maintains an award-winning team with expertise in cardiac technology development.

Organizations should consider HeartBeam when seeking a portable ECG solution that balances clinical-grade accuracy with patient convenience. The integrated service model combining device technology with cardiologist interpretation may appeal to practices looking to extend cardiac monitoring capabilities without building internal infrastructure.

Potential partners should expect to work with an innovative medical device company in growth stages. The waitlist model suggests interest should be registered early for access. The technology appears best suited for cardiac monitoring programs where synthesized 12-lead ECG data and rapid physician interpretation add clinical value over consumer wearables.

HeartBeam operates exclusively in the healthcare sector as a medical device manufacturer focused on cardiac monitoring. The company serves cardiology practices, health systems, and healthcare providers requiring clinical-grade ECG data for cardiac patients. Their FDA-cleared device and integrated cardiologist review services address specific clinical needs in remote cardiac monitoring, particularly for patients experiencing intermittent cardiac symptoms that may not be captured during scheduled office visits.

The technology targets the clinical gap between hospital-based 12-lead ECG equipment and consumer wearables, positioning itself as a medical-grade solution for cardiac diagnostics in home and ambulatory settings.

Cardiology practices, health systems, and healthcare organizations implementing remote cardiac monitoring programs for patients experiencing chest pain or cardiac symptoms between clinical visits. Organizations prioritizing clinical-grade ECG data quality over consumer-grade wearable alternatives and seeking turnkey solutions with integrated physician interpretation services.